Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New E-NPP 2 inhibitors identified at Roche

July 3, 2020

LAMC2 identified as a therapeutic target in PDAC

July 3, 2020

Phase III study of pracinostat plus azacytidine in AML discontinued due to lack of efficacy

July 3, 2020

MANIFEST study results of CPI-0610 in advanced myelofibrosis set up phase III study

July 3, 2020

Chinese phase I study evaluates TQB-3558 for solid tumors

July 2, 2020

Promising efficacy of SJP-1602 in models of TNBC

July 2, 2020

Menarini plans phase Ib/II study of MEN-1611 in metastatic colorectal cancer

July 2, 2020

Emerald Health Biotechnology Espana identifies monoglyceride lipase inhibitors

July 2, 2020

Lynk Pharmaceuticals patents Janus kinase inhibitors

July 2, 2020

Bayer, Deutsches Krebsforschungszentrum present new MAP4K1 inhibitors

July 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...